Home    About NDEI   Site Map   FAQ   Contact Us   Feedback   
       Advanced Search    
Home
Slide Library
Literature Alerts
On Demand Activities
Case Studies
Newsletters
Live Events
Treatment Guidelines
Patient Education
Clinical Trials
Product Indications
Calendar Of Events
Glossary
Other Resources
CME Opportunities


Your Online Resource for Diabetes Treatment
Home > Literature Alerts > What Is an Optimal Diet? Relationship of...
Printer-Friendly Format
Email this to a friend
Highlight Glossary

International Journal of Obesity

What Is an Optimal Diet? Relationship of Macronutrient Intake to Obesity, Glucose Tolerance, Lipoprotein Cholesterol Levels and the Metabolic Syndrome in the Whitehall II Study
EJ Brunner, H Wunsch & MG Marmot
International J Obesity. 2001;25:45-53.

OBJECTIVE: Saturated fats have adverse effects on health. To investigate which is more beneficial for energy replacement, we compare the effects of polyunsaturated fatty acid and carbohydrate intake on obesity and metabolic variables (fasting triglycerides, HDL-cholesterol, LDL-cholesterol and 2 h glucose). Further, because the optimum diet may differ according to glucose tolerance, we examine the same associations in glucose tolerant and intolerant groups. Finally, we test the effect of macronutrient intake on the presence or absence of the metabolic syndrome.

DESIGN: Cross-sectional analysis.

SUBJECTS: A total of 4497 men and 1865 women aged 39–62 in the Whitehall II study.

RESULTS: In men, higher intakes of both polyunsaturated fats and carbohydrates were linked to lower waist–hip ratio, triglycerides and LDL-cholesterol. Higher carbohydrate intake alone was linked to decreased body mass index (for 10 g higher carbohydrate intake, -0.12 kg/m2, P<0.0001) and lower HDL-cholesterol (-0.01 mmol/l, P<0.01). In normoglycaemic men, higher carbohydrate intakes were associated with higher 2 h insulin and glucose levels (0.25 pmol/l, P<0.05 and 0.01 mmol/l, P=0.001, respectively). Dietary effects among women were similar, the exception being a positive association of polyunsaturated fat intake with body mass index and waist–hip ratio (0.47 kg/m2, P<0.05 and 0.006, P<0.05, respectively). Dietary components, with the exceptions of cholesterol and protein in men, were unrelated to prevalence of the metabolic syndrome, and adjustment for differences in macronutrient intake did not account for the strong inverse association between socioeconomic position and the metabolic syndrome.

CONCLUSION: Our observational data provide evidence that both polyunsaturated fatty acids and carbohydrates offer small metabolic benefits with few adverse effects compared with saturated fats.

The full text of this article is available online.

Brunner EJ, Wunsch H, Marmot MG. What Is an Optimal Diet? Relationship of Macronutrient Intake to Obesity, Glucose Tolerance, Lipoprotein Cholesterol Levels and the Metabolic Syndrome in the Whitehall II Study. Int J Obesity. 2001;25:45-53.
 Additional Information   Additional Information
ArticleDietary Fat and Meat Intake in Relation to Risk of Type 2 Diabetes in Men

ArticleDietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men

ArticleDietary fat intake and risk of type 2 diabetes in women

ArticleIntensive Lifestyle Changes Are Necessary to Improve Insulin Sensitivity: A Randomized Controlled Trial

ArticleA Flexible, Low-Glycemic Index Mexican-Style Diet in Overweight and Obese Subjects With Type 2 Diabetes Improves Metabolic Parameters During a 6-Week Treatment Period

ArticleLow–Glycemic Index Diets in the Management of Diabetes. A Meta-Analysis of Randomized Controlled Trials

ArticleThe Metabolic Response of Subjects with Type 2 Diabetes to a High-Protein, Weight-Maintenance Diet

ArticleAssociations of Dietary Fiber With Glucose Metabolism in Nondiabetic Relatives of Subjects With Type 2 Diabetes. The Botnia Dietary Study

 

Clinical Bridges, Secaucus, NJ
Clinical Bridges is a division of KnowledgePoint360 Group, LLC.
Copyright © 2009 Clinical Bridges. All rights reserved.
National Diabetes Education Initiative, Clinical Bridges, and
KnowledgePoint360 are trademarks of KnowledgePoint360 Group, LLC.
Disclaimer Statement - Privacy Statement